ArticleACS applied materials & interfaces2025
Wet/Dry Bottlebrush Pressure Sensitive Adhesives via a Dangling Defect-Driven Design.
Article in ACS applied materials & interfaces, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
A series of bottlebrush pressure sensitive adhesives (PSAs) containing progressively greater numbers of large dangling ends were synthesized using ring-opening metathesis polymerization. These defects were engineered into PSAs by promoting the formation of loop defects and by manipulating the kinetic chain length such that large dangling defects are covalently bound to the bulk. The unique structure of these samples is shown to promote adhesion at interfaces by maximizing surface area contact and increasing local van der Waals forces. This design philosophy (termed defect-driven design,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.